Stay updated with breaking news from David Germonpr. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Patient population benefitting most from enibarcimab treatment in septic shock can clearly be defined by two biomarkers, as shown by data presented todayIn the AdrenOSS-2 trial, the respective patient subgroup had a
Adrenomed AG, the vascular integrity company, today announced the appointment of David Germonpré as Chief Financial Officer (CFO) of Adrenomed, effective July 11, 2022.
DGAP-News: Adrenomed AG / Key word(s): PersonnelAdrenomed appoints David Germonpré as Chief Financial Officer 12.07.2022 / 09:30 The issuer is solely responsible for the content of this announcement.Adrenomed appoints David Germonpré as Chief Financial Officer Hennigsdorf/Berlin (Germany), July 12, 2022 – Adrenomed...